Sentences with phrase «other venture capital companies»

First Mile, owned byNortel Networks and other venture capital companies, provides bundled technology services in new home communities.

We want to partner with entrepreneurs and other venture capital companies that can help bring new approaches to meet some of the challenges that our customers face.

Not exact matches

But, at least in the venture capital world, funding for companies focused on tackling heart disease, respiratory disease, and other mass population conditions — i.e., those that afflict millions upon millions of people — has dropped sharply in the last decade.

Here's her advice for other female founders who also think venture capital might be the best source of funds for their companies.

In a recent valuation, the company became the only venture - capital - backed startup other than Facebook to ever reach a $ 50 billion valuation.

By contrast, women who raise A rounds in the Bay Area, «tend to have more technical backgrounds and many are serial entrepreneurs who have raised venture capital while running other companies.»

DST Global, a company that was early investors in Facebook and Spotify, led the funding round, which included other high profile venture capital firms Index Ventures and Ribbit Ccapital firms Index Ventures and Ribbit CapitalCapital.

More generally, other Chinese companies will look at strategic investments in tech startups, much the way Google and Intel do now through their venture capital arms.

Additionally, JetBlue Technology Ventures is investing alongside GGV and other venture firms in a $ 36 million series C round of funding for Gladly, bringing the company's total capital raised to $ 63 million.

Huang says the company, which is not yet profitable and raised $ 132 million in venture capital from American Express Ventures, Bessemer Venture Partners, DST Global, and others, could have maximized margins and increased savings by reducing staff, but he told the board that he felt the company would be more profitable in the long term if it dedicated itself to its empventure capital from American Express Ventures, Bessemer Venture Partners, DST Global, and others, could have maximized margins and increased savings by reducing staff, but he told the board that he felt the company would be more profitable in the long term if it dedicated itself to its empVenture Partners, DST Global, and others, could have maximized margins and increased savings by reducing staff, but he told the board that he felt the company would be more profitable in the long term if it dedicated itself to its employees.

The fact that companies today are building most of their value pre-IPO versus post-IPO (if they IPO at all) means that investors who don't have access to high - quality venture capital and other private opportunities are missing out on considerable gains.

Private companies now have an unprecedented ability to raise late - stage venture and other private capital to finance their innovation and investment, often on equal or better terms than in the public markets and with less hassle.

In fact, there are more unicorns now than at any other time in the past four years, thanks in part to free - flowing venture capital, and investors seeking big payoffs for companies they hope will be the next Facebook or Google.

This metropolitan area (which includes Oakland and Fremont, Calif.) saw the largest proportion of venture capital - backed business exits over the past year compared to other major cities, meaning there are a large number of what Kauffman identifies as «growth companies» in San Francisco and the East Bay.

One of the venture capital firms behind Leap Motion, a company that has developed a 3 - D gesture - control technology, is offering entrepreneurs $ 25 million to create apps and other technology for the platform.

Entrepreneurs listened, at least to the second part: U.S. - based companies raised more venture capital in the fourth quarter of 2014 than they did in any other quarter over the prior 13 years, according to the National Venture Capital Assocventure capital in the fourth quarter of 2014 than they did in any other quarter over the prior 13 years, according to the National Venture Capital Assoccapital in the fourth quarter of 2014 than they did in any other quarter over the prior 13 years, according to the National Venture Capital AssocVenture Capital AssocCapital Association.

Take the private - equity marketplace, a broadly defined investment sector that includes venture capitalists, large and small angel investors, hedge funds, private investment pools, and even insurance companies and other institutional players that either participate through money - management funds or make direct capital investments in growth companies.

In 1981, Digital Research had revenues of $ 6 million; for 1982, it forecasts revenues of $ 20 million.The company, which now employs 75 people, has acquired two other software firms and was one of the first in the industry to accept venture capital.

Floreani's company has raised nearly $ 30 million in funding thus far, including $ 21.2 million in Series B venture capital funding last year that came from a group led by DCM Ventures and Bertelsmann Digital Media Investments, along with other investors including Discovery Communications and World Wrestling Entertainment.

In March 2014, Saverin and seven other investors, including American venture capital firm, Bessemer Venture Partners, reportedly invested about $ 6.65 million in Singapore - based cloud computing start - up company, Nventure capital firm, Bessemer Venture Partners, reportedly invested about $ 6.65 million in Singapore - based cloud computing start - up company, NVenture Partners, reportedly invested about $ 6.65 million in Singapore - based cloud computing start - up company, Nitrous.

There are other issues to settle, including the explosive lawsuit filed by Benchmark Capital — which owns more than 10 percent of the company and has a board seat held by Matt Cohler — against Kalanick, whom the venture firm helped oust and has been trying to restrain.

Benchmark Capital will end up selling about $ 900 million of its Uber stock to SoftBank and other buyers, or about 14.5 percent of the venture capital firm's holdings in the company, according to people familiar with the transCapital will end up selling about $ 900 million of its Uber stock to SoftBank and other buyers, or about 14.5 percent of the venture capital firm's holdings in the company, according to people familiar with the transcapital firm's holdings in the company, according to people familiar with the transaction.

Fortune Brainstorm Health, in association with IBM Watson Health, gathers not only C - suite leaders of top companies, hospitals, insurers, and cutting - edge pharma and biotech companies, but also titans of venture capital, tech and telecom, and other industries, all of who are rapidly changing the face of health care.

Because of the nature of the business, private equity and venture capital investors tend to devote their time, energy and finances to helping other companies grow.

Banks and financial services companies have been the most active investors — either through internal venture capital arms or through other strategic initiatives.

Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward - looking statements include, but are not limited to, increased competition; the Company's ability to maintain, extend and expand its reputation and brand image; the Company's ability to differentiate its products from other brands; the consolidation of retail customers; the Company's ability to predict, identify and interpret changes in consumer preferences and demand; the Company's ability to drive revenue growth in its key product categories, increase its market share, or add products; an impairment of the carrying value of goodwill or other indefinite - lived intangible assets; volatility in commodity, energy and other input costs; changes in the Company's management team or other key personnel; the Company's inability to realize the anticipated benefits from the Company's cost savings initiatives; changes in relationships with significant customers and suppliers; execution of the Company's international expansion strategy; changes in laws and regulations; legal claims or other regulatory enforcement actions; product recalls or product liability claims; unanticipated business disruptions; failure to successfully integrate the Company; the Company's ability to complete or realize the benefits from potential and completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions in the nations in which the Company operates; the volatility of capital markets; increased pension, labor and people - related expenses; volatility in the market value of all or a portion of the derivatives that the Company uses; exchange rate fluctuations; disruptions in information technology networks and systems; the Company's inability to protect intellectual property rights; impacts of natural events in the locations in which the Company or its customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; the Company's dividend payments on its Series A Preferred Stock; tax law changes or interpretations; pricing actions; and other factors.

Start - up companies in other industries such as technology and biotechnology have had less traction in attracting venture capital investment in similar demographic proportions.

Plant - based meat companies have been seeing larger and larger rounds from venture capital and other types of investors.

Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward - looking statements include, but are not limited to, operating in a highly competitive industry; changes in the retail landscape or the loss of key retail customers; the Company's ability to maintain, extend and expand its reputation and brand image; the impacts of the Company's international operations; the Company's ability to leverage its brand value; the Company's ability to predict, identify and interpret changes in consumer preferences and demand; the Company's ability to drive revenue growth in its key product categories, increase its market share, or add products; an impairment of the carrying value of goodwill or other indefinite - lived intangible assets; volatility in commodity, energy and other input costs; changes in the Company's management team or other key personnel; the Company's ability to realize the anticipated benefits from its cost savings initiatives; changes in relationships with significant customers and suppliers; the execution of the Company's international expansion strategy; tax law changes or interpretations; legal claims or other regulatory enforcement actions; product recalls or product liability claims; unanticipated business disruptions; the Company's ability to complete or realize the benefits from potential and completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions in the United States and in various other nations in which we operate; the volatility of capital markets; increased pension, labor and people - related expenses; volatility in the market value of all or a portion of the derivatives we use; exchange rate fluctuations; risks associated with information technology and systems, including service interruptions, misappropriation of data or breaches of security; the Company's ability to protect intellectual property rights; impacts of natural events in the locations in which we or the Company's customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; the Company's ownership structure; the impact of future sales of its common stock in the public markets; the Company's ability to continue to pay a regular dividend; changes in laws and regulations; restatements of the Company's consolidated financial statements; and other factors.

Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward - looking statements include, but are not limited to, increased competition; the Company's ability to maintain, extend and expand its reputation and brand image; the Company's ability to differentiate its products from other brands; the consolidation of retail customers; the Company's ability to predict, identify and interpret changes in consumer preferences and demand; the Company's ability to drive revenue growth in its key product categories, increase its market share or add products; an impairment of the carrying value of goodwill or other indefinite - lived intangible assets; volatility in commodity, energy and other input costs; changes in the Company's management team or other key personnel; the Company's inability to realize the anticipated benefits from the Company's cost savings initiatives; changes in relationships with significant customers and suppliers; execution of the Company's international expansion strategy; changes in laws and regulations; legal claims or other regulatory enforcement actions; product recalls or product liability claims; unanticipated business disruptions; failure to successfully integrate the business and operations of the Company in the expected time frame; the Company's ability to complete or realize the benefits from potential and completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions in the nations in which the Company operates; the volatility of capital markets; increased pension, labor and people - related expenses; volatility in the market value of all or a portion of the derivatives that the Company uses; exchange rate fluctuations; risks associated with information technology and systems, including service interruptions, misappropriation of data or breaches of security; the Company's inability to protect intellectual property rights; impacts of natural events in the locations in which the Company or its customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; tax law changes or interpretations; and other factors.

Social Capital kicked off a trial of Carroll's model last year with a referral program of sorts — the fund asked other venture capital firms to direct promising early - stage companies to apply through the Capital kicked off a trial of Carroll's model last year with a referral program of sorts — the fund asked other venture capital firms to direct promising early - stage companies to apply through the capital firms to direct promising early - stage companies to apply through the system.

An increasing number of Angels are leveraging investment into their portfolio companies by syndicating with other Angel investors (61 %) and Venture Capital funds (32 %)

Due diligence is a rigorous process that determines whether or not the venture capital fund or other investor will invest in your company.

Two companies backed by venture capital have been recent buyers: Halifax Media Group (buyer of the Worcester Telegram & Gazette and a couple of others since its purchase of the New York Times Company's Regional Newspaper Group in 2012) and the new Gatehouse / New Media (recent buyer of the Providence Journal), which has announced a $ 150 - $ 300 million war chest for newspaper company purCompany's Regional Newspaper Group in 2012) and the new Gatehouse / New Media (recent buyer of the Providence Journal), which has announced a $ 150 - $ 300 million war chest for newspaper company purcompany purchases.

Filing for intellectual property protection for a venture Capital business goes beyond protecting your company's logo and other documents, but also protecting your investments, patents and of course the name of your company.

Description: As one of the few women leading a venture capital firm in the United States, Sara Brand specifically seeks out other female - led companies to invest in.

It is closely following other global food companies in creating venture vehicles to invest in growth independent brands and food start - ups, such as Kellogg's new venture fund, Eighteen94 Capital.

[Subordination: The Note shall be subordinated to all indebtedness of the Company to banks, commercial finance lenders, insurance companies, [leasing or equipment financing institutions] or other lending institutions regularly engaged in the business of lending money -LSB-(excluding venture capital, investment banking or similar institutions which sometimes engage in lending activities but which are primarily engaged in investments in equity securities)-RSB-, which is for money borrowed, [or purchase or leasing of equipment in the case of lease or other equipment financing,] whether or not secured.]

With Google becoming Alphabet, the company's internet business and other ventures remain the same under a capital structure of more equity and less debt.

GFI reports that as their scientists investigate further, they have become more optimistic — because clean meat is so much more efficient than animal - based meat.102 One of their senior scientists, Dr. Liz Specht, has met with venture capital firms and other venture investors to present technology plans of specific clean meat companies and their pathways to commercialization.103 GFI further reports that, based partly on her analysis, many leading venture capital investors and firms have become much more interested in clean meat companies.

Hear from cyber-security experts, company founders, venture capital firms, and other CISOs on how organizations are innovating to change the battle - field of cyber attacks.

A major storyline in venture capital has been the issue of sexual harassment and sexism towards women — particularly company founders but also other investment professionals.

In a typical Reg A + offering, a company will not need to cede board seats or agree to other potentially adverse mechanisms that are typical when raising venture capital or private equity.

GFI reports that as their scientists investigate further, they have become more optimistic — because clean meat is so much more efficient than animal - based meat.102 One of their senior scientists, Dr. Liz Specht, has met with venture capital firms and other venture investors to present technology plans of specific clean meat companies and their pathways to commercialization.103 GFI further reports that, based partly on her analysis, many leading venture capital investors and firms have become much more interested in clean meat companies.

Armed with $ 1.5 billion in venture capital, Uber is waging a stealth campaign to undermine Lyft and other transportation networking companies, reports Casey Newton for the Verge.

Crucially, the new organization will partner a host of other institutions such as Ghana Investment Promotion Centre, providers of mobile money services, cooperatives, Town & Country Planning Department, Council for Scientific and Industrial Research, National Board for Small Scale Industries, GRATIS Foundation, Venture Capital Trust Fund, the commercial and investment banks, insurance companies, and of course, the District Assemblies themselves.

Some have made the transition through MBAs or business degrees, while others have entered venture capital after getting some experience in a start - up company.

Venture capital (VC) and other private equity firms are pools of capital, typically organized as a limited partnership, that invest in companies that show the potential for a high rate of return.

Once these companies are established with this funding, Foundation Venture Capital Group, LLC, will seek to work with other traditional venture capital companies to partner in the effort to advance these technologies and comVenture Capital Group, LLC, will seek to work with other traditional venture capital companies to partner in the effort to advance these technologies and comCapital Group, LLC, will seek to work with other traditional venture capital companies to partner in the effort to advance these technologies and comventure capital companies to partner in the effort to advance these technologies and comcapital companies to partner in the effort to advance these technologies and companies.

Table 1: Selection, Design & Construction of HSV - based Oncolytic Viruses Table 2: Selection, Design & Construction of Adenovirus - based Oncolytic Viruses Table 3: Selection, Design & Construction of Vaccinia Virus - based Oncolytic Viruses Table 4: Selection, Design & Construction of Vesicular Stomatitis Virus - based Oncolytic Viruses Table 5: Selection, Design & Construction of Newcastle Disease Virus - based Oncolytic Viruses Table 6: Selection, Design & Construction of Various Virus - based Oncolytic Viruses Table 7: Current Company - Sponsored Clinical Trials of T - Vec Table 8: Clinical Trials of ColoAd1 Table 9: Clinical Trials with JX - 594 Table 10: Clinical Trials with GL - ONC1 Table 11: Clinical Trials of CAVATAK (CVA21) Table 12: Clinical Trials with MV - NIS Table 13: Overview of Oncolytic Viruses by Development Phase & Virus Family Table 14: Profile of Approved and Marketed Oncolytic Viruses Table 15: Pivotal Study Design of Oncolytic Viruses in Late Stage Development Based on Previous Clinical Results Table 16: Approved Indications of Immune Checkpoint Inhibitors Table 17: Active Clinical Studies of Oncolytic Viruses in Combination with Immune Checkpoint Inhibitors (ICI) Table 18: Planned Clinical Studies of Oncolytic Viruses in Combination with Immune Checkpoint Inhibitors (ICI) Table 19: Active or Planned Clinical Studies of Oncolytic Viruses in Combination with Other Anti-Cancer Therapeutics Table 20: Pattern of Transgenes in Oncolytic Viruses in Relation to Development Phase Tables 21a and 21b: Indications and Frquency and Way of Administration of Oncolytic Viruses in Active and / or Positive Completed Clinical Studies Table 22: Small and Medium Pharma & Biotech as Partner for Regional Co-Development of Oncolytic Viruses Table 23: Immuno - Oncology Portfolio of Major Pharma & Biotech with Interest in Oncolytic Viruses Table 24: Interests of Major Pharma & Biotech in Oncolytic Viruses Table 25: First Generation Oncology Virus Companies and their Sources of Technology Table 26: Second Generation Oncology Virus Companies and their Sources of Technology Table 27: Third Generation Oncology Virus Companies and their Sources of Technology Table 28: Fourth Generation Oncology Virus Companies and their Sources of Technology Table 29: Grants, Credits & Donations Table 30: Financing by Venture Capital, Private Equity and Other Private Placements Table 31: Collaboration & Licensing Agreements Table 32: Companies Listed on Stock Exchange & Offerings Table 33: Mergers & Acquisitions